- Entry
- $13.22
- Now
- $11.68 -11.6%
- Target
- —
- Score
- —
$TNXP / TONMYA – Executive Summary (Week Ended 6/12/2026): Another week of steady commercial momentum for TONMYA. The latest prescription data continues to point to a strong launch trajectory: 🚀TRx: 859 vs. 840 last week (+19 WoW). 💪 🚀NRx: 579 vs. 603 (-24 WoW), a modest normalization in new prescriptions, more than offset by continued growth in refill activity. 🚀Weekly gross sales: $1.394M vs. $1.312M (+$82K / +6.3% WoW). 🚀 🚀Implied annual gross sales run rate: $60.5M, up from $57.8M …
— ORIGINAL POST ·
$TNXP -> +10,35% friday, why??
· r/Shortsqueeze
· Jun 28, 2026